Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Companion Animal Vaccines Market By Product Type, By Disease Type, By Vaccine Type, By Distribution Channel and Geography
Companion Animal Vaccines Market By Product Type, By Disease Type, By Vaccine Type, By Distribution Channel and Geography
Companion Animal Vaccines Market was valued at US$ 3.3 billion in 2023 and is poised to grow at a CAGR of 6.6% from 2024-2030. Companion animals such as dogs, cats, and horses are becoming more common in cities. The growing prevalence of various animal diseases, technological advancements in diagnostic and therapeutic with efficient drugs, developments in the field of biotechnology, and growing consumer awareness as a result of social media government initiatives are all driving demand in the global market for companion animal vaccines. Various countries have enacted strict regulations to conserve and safeguard companion animals, which must be accompanied by regular animal health checks.
However, growing vaccine storage costs and insufficient reporting methods are preventing the global companion animal vaccines business from reaching its full potential. Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the caregivers and pet owners to adopt better healthcare services to the companion animals this is projected to drive market revenue growth over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
6.6%Largest Market
North AmericaFastest Growing Market
Asia Pacific
There has been a rise in awareness regarding pet health among pet owners across the developed and developing economies expected to drive market revenue growth over the forecast period. Moreover, several studies on human and companion animal interactions showed that association with companion animals results in positive health benefits. Therefore, it is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are the primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal vaccines over the forecast period.
Companion animal vaccines market report gives a comprehensive outlook on companion animal vaccines across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). North America market leads the global companion animal health vaccines and projected to remain same over the forecast period owing to large pet ownership. According to data from American Pet Products association as of 2016, around 40% of households owned one or the other pet animals. Europe Veterinary Vaccines Market holds significant share in global market. Increased product introduction in Europe vaccine against Leishmania infantum, the causal agent of canine leishmaniosis which is significant breakthrough against zoonotic disease is one of the factors driving the market positively.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 3.3 billion |
|
Market CAGR |
6.6% |
|
By Product Type |
|
|
By Disease Type |
|
|
By Vaccine Type |
|
|
By Distribution Channel |
|
Download Free Sample Report
The global companion animal vaccines market size was valued at US$ 3.3 billion in 2023 and is projected to grow at a CAGR of 6.6% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Bayer AG (Germany) Boehringer Ingelheim GmbH (Germany) Ceva Santé Animale (France) Eli Lilly and Company (U.S) Heska Co. (U.S) Hester biosciences (India)
| 1.Executive Summary |
| 2.Global Companion Animal Vaccines Market Introduction |
| 2.1.Global Companion Animal Vaccines Market - Taxonomy |
| 2.2.Global Companion Animal Vaccines Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Disease Type |
| 2.2.3.Vaccine Type |
| 2.2.4.Distribution Channel |
| 2.2.5.Region |
| 3.Global Companion Animal Vaccines Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Companion Animal Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Companion Animal Vaccines Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Canine Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Feline Vaccines |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Avian Vaccines |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Equine Vaccines |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Companion Animal Vaccines Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Canine Distemper |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Canine Parvovirus |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Feline Rabies |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Companion Animal Vaccines Market By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Live Attenuated Vaccines |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Inactivated Vaccines |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Recombinant vaccines |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Toxoid vaccines |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Conjugate Vaccines |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. DNA Vaccines |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Subunit Vaccines |
| 7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Companion Animal Vaccines Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Veterinary Pharmacies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Veterinary Hospitals |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Veterinary Clinics |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. E-Commerce |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Global Companion Animal Vaccines Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Canine Vaccines |
| 10.1.2.Feline Vaccines |
| 10.1.3.Avian Vaccines |
| 10.1.4.Equine Vaccines |
| 10.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Canine Distemper |
| 10.2.2.Canine Parvovirus |
| 10.2.3.Feline Rabies |
| 10.2.4.Others |
| 10.3. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Live Attenuated Vaccines |
| 10.3.2.Inactivated Vaccines |
| 10.3.3.Recombinant vaccines |
| 10.3.4.Toxoid vaccines |
| 10.3.5.Conjugate Vaccines |
| 10.3.6.DNA Vaccines |
| 10.3.7.Subunit Vaccines |
| 10.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Veterinary Pharmacies |
| 10.4.2.Veterinary Hospitals |
| 10.4.3.Veterinary Clinics |
| 10.4.4.E-Commerce |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Canine Vaccines |
| 11.1.2.Feline Vaccines |
| 11.1.3.Avian Vaccines |
| 11.1.4.Equine Vaccines |
| 11.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Canine Distemper |
| 11.2.2.Canine Parvovirus |
| 11.2.3.Feline Rabies |
| 11.2.4.Others |
| 11.3. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Live Attenuated Vaccines |
| 11.3.2.Inactivated Vaccines |
| 11.3.3.Recombinant vaccines |
| 11.3.4.Toxoid vaccines |
| 11.3.5.Conjugate Vaccines |
| 11.3.6.DNA Vaccines |
| 11.3.7.Subunit Vaccines |
| 11.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Veterinary Pharmacies |
| 11.4.2.Veterinary Hospitals |
| 11.4.3.Veterinary Clinics |
| 11.4.4.E-Commerce |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Canine Vaccines |
| 12.1.2.Feline Vaccines |
| 12.1.3.Avian Vaccines |
| 12.1.4.Equine Vaccines |
| 12.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Canine Distemper |
| 12.2.2.Canine Parvovirus |
| 12.2.3.Feline Rabies |
| 12.2.4.Others |
| 12.3. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Live Attenuated Vaccines |
| 12.3.2.Inactivated Vaccines |
| 12.3.3.Recombinant vaccines |
| 12.3.4.Toxoid vaccines |
| 12.3.5.Conjugate Vaccines |
| 12.3.6.DNA Vaccines |
| 12.3.7.Subunit Vaccines |
| 12.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Veterinary Pharmacies |
| 12.4.2.Veterinary Hospitals |
| 12.4.3.Veterinary Clinics |
| 12.4.4.E-Commerce |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Companion Animal Vaccines Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Canine Vaccines |
| 13.1.2.Feline Vaccines |
| 13.1.3.Avian Vaccines |
| 13.1.4.Equine Vaccines |
| 13.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Canine Distemper |
| 13.2.2.Canine Parvovirus |
| 13.2.3.Feline Rabies |
| 13.2.4.Others |
| 13.3. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Live Attenuated Vaccines |
| 13.3.2.Inactivated Vaccines |
| 13.3.3.Recombinant vaccines |
| 13.3.4.Toxoid vaccines |
| 13.3.5.Conjugate Vaccines |
| 13.3.6.DNA Vaccines |
| 13.3.7.Subunit Vaccines |
| 13.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Veterinary Pharmacies |
| 13.4.2.Veterinary Hospitals |
| 13.4.3.Veterinary Clinics |
| 13.4.4.E-Commerce |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Companion Animal Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Canine Vaccines |
| 14.1.2.Feline Vaccines |
| 14.1.3.Avian Vaccines |
| 14.1.4.Equine Vaccines |
| 14.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Canine Distemper |
| 14.2.2.Canine Parvovirus |
| 14.2.3.Feline Rabies |
| 14.2.4.Others |
| 14.3. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Live Attenuated Vaccines |
| 14.3.2.Inactivated Vaccines |
| 14.3.3.Recombinant vaccines |
| 14.3.4.Toxoid vaccines |
| 14.3.5.Conjugate Vaccines |
| 14.3.6.DNA Vaccines |
| 14.3.7.Subunit Vaccines |
| 14.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Veterinary Pharmacies |
| 14.4.2.Veterinary Hospitals |
| 14.4.3.Veterinary Clinics |
| 14.4.4.E-Commerce |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Bayer AG (Germany) |
| 15.2.2.Boehringer Ingelheim GmbH (Germany) |
| 15.2.3.Ceva Santé Animale (France) |
| 15.2.4.Eli Lilly and Company (U.S) |
| 15.2.5.Heska Co. (U.S) |
| 15.2.6.Hester biosciences (India) |
| 15.2.7.Merck & Co., Inc. (U.S) |
| 15.2.8.Vétoquinol S.A. (France) |
| 15.2.9.Virbac S.A. (France) |
| 15.2.10.Zoetis Inc. (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.